This section explores the mechanisms by which JAK2 mutations disrupt autophagic regulation in macrophages and how this dysregulation accelerates atherosclerosis, setting the stage for understanding potential therapeutic interventions targeting JAK2 and autophagic pathways in atherosclerosis [71,166]. The gene discussed is JAK2; the disease is atherosclerosis.